Overview
Weicheng Chen practices in Shanghai, China. Chen is rated as an Advanced expert by MediFind in the treatment of Tetralogy of Fallot. Their top areas of expertise are Heterotaxy Syndrome, Congenital Heart Disease (CHD), Situs Inversus, Tetralogy of Fallot, and Vertebroplasty.
Their clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Tetralogy of Fallot.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Heterotaxy SyndromeChen isDistinguished. Learn about Heterotaxy Syndrome.
- Advanced
- Achard SyndromeChen isAdvanced. Learn about Achard Syndrome.
- ArachnodactylyChen isAdvanced. Learn about Arachnodactyly.
- Congenital Heart Disease (CHD)
- Situs InversusChen isAdvanced. Learn about Situs Inversus.
- Tetralogy of FallotChen isAdvanced. Learn about Tetralogy of Fallot.
- Ventricular Septal Defects
- Experienced
- Acromicric DysplasiaChen isExperienced. Learn about Acromicric Dysplasia.
- Ataxia-TelangiectasiaChen isExperienced. Learn about Ataxia-Telangiectasia.
- BronchiectasisChen isExperienced. Learn about Bronchiectasis.
- CHARGE SyndromeChen isExperienced. Learn about CHARGE Syndrome.
- Ciliary Dyskinesia-Bronchiectasis
- CraniosynostosisChen isExperienced. Learn about Craniosynostosis.